Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review

Date: August 2, 2016
Pages: 53
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: JFFDCA361D1EN
Leaflet:

Download PDF Leaflet

Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Jubilant Life Sciences Limited (Jubilant) is an integrated pharmaceutical and life sciences company that carries out the manufacture and supply of radiopharmaceuticals, allergy therapy products, active pharmaceutical ingredients (APIs), solid dosage formulations, life science chemicals, nutritional products, fine ingredients, advance intermediates and crop science ingredients. It also provides contract manufacturing of sterile injectables and drug discovery and development services. The company caters its products and services to customers across India, North America, Canada, Europe and China. It owns and operates cGMP compliant manufacturing facilities, and research and development centers in India, the US and Canada. Jubilant is headquartered in Noida, Uttar Pradesh, India.

Jubilant Life Sciences Limited Key Recent Developments

May 24, 2016: Jubilant Life Sciences announces board changes
May 24, 2016: Jubiliant life sciences reports Q4 & FY 2016 results
Mar 29, 2016: Jubilant Innovation Receives Upfront Payment and Potential Milestones from Its Investment
Feb 19, 2016: Jubilant Reports Strong Profitability Q3 FY2016 EBITDA at Rs. 310 Crore, UP 62% YOY and PAT at Rs. 117 Crore
Feb 06, 2016: Ministry of Commerce China has reduced the Anti-Dumping Duty on Pyridine from Jubilant to 17.6%

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Jubilant Life Sciences Limited - Key Facts
Jubilant Life Sciences Limited - Key Employees
Jubilant Life Sciences Limited - Key Employee Biographies
Jubilant Life Sciences Limited - Major Products and Services
Jubilant Life Sciences Limited - History
Jubilant Life Sciences Limited - Company Statement
Jubilant Life Sciences Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Jubilant Life Sciences Limited - Business Description
Jubilant Life Sciences Limited - Corporate Strategy
Jubilant Life Sciences Limited - SWOT Analysis
SWOT Analysis - Overview
Jubilant Life Sciences Limited - Strengths
Strength - Focused Research and Development Activities
Strength - Pharmaceuticals Segment
Strength - Operational Efficiency
Jubilant Life Sciences Limited - Weaknesses
Weakness - Declining Performance of Life Sciences Ingredients Segment
Jubilant Life Sciences Limited - Opportunities
Opportunity - New Agreements
Opportunity - Regulatory Approvals
Opportunity - Vertically Integrated Operations
Jubilant Life Sciences Limited - Threats
Threat - Intense Competition
Threat - Industry Consolidation
Threat - Stringent Industry Regulations
Jubilant Life Sciences Limited - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Jubilant Life Sciences Limited, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

May 24, 2016: Jubilant Life Sciences announces board changes
May 24, 2016: Jubiliant life sciences reports Q4 & FY 2016 results
Mar 29, 2016: Jubilant Innovation Receives Upfront Payment and Potential Milestones from Its Investment
Feb 19, 2016: Jubilant Reports Strong Profitability Q3 FY2016 EBITDA at Rs. 310 Crore, UP 62% YOY and PAT at Rs. 117 Crore
Feb 06, 2016: Ministry of Commerce China has reduced the Anti-Dumping Duty on Pyridine from Jubilant to 17.6%
Aug 11, 2015: Jubilant Life Sciences: Financial Results for the quarter ended June 30, 2015
Jun 12, 2015: Jubilant’s Spokane facility successfully concludes inspection status
May 12, 2015: Jubilant Life Sciences – Q4 & FY 2015 Results
Feb 03, 2015: Jubilant Life Sciences- Q3 & 9M FY2015 Results
Jan 06, 2015: Appointment of Mr. GP Singh as CEO - Jubilant Pharma

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Jubilant Life Sciences Limited, Key Facts
Jubilant Life Sciences Limited, Key Employees
Jubilant Life Sciences Limited, Key Employee Biographies
Jubilant Life Sciences Limited, Major Products and Services
Jubilant Life Sciences Limited, History
Jubilant Life Sciences Limited, Other Locations
Jubilant Life Sciences Limited, Subsidiaries
Jubilant Life Sciences Limited, Joint Venture
Jubilant Life Sciences Limited, Key Competitors
Jubilant Life Sciences Limited, Ratios based on current share price
Jubilant Life Sciences Limited, Annual Ratios
Jubilant Life Sciences Limited, Interim Ratios
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Jubilant Life Sciences Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Jubilant Life Sciences Limited, Performance Chart (2012 - 2016)
Jubilant Life Sciences Limited, Ratio Charts
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Jubilant Life Sciences Limited, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Teva Pharmaceutical Industries Ltd.
Tata Chemicals Limited
Hetero Drugs Limited
Dr. Reddy's Laboratories Limited
Divi's Laboratories Limited
BASF India Limited
Atul Limited
Aditya Birla Chemicals (India) Limited
Skip to top


Ask Your Question

Jubilant Life Sciences Limited (JUBILANT) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: